ReviewBMC public health2019
Promoting population health with public-private partnerships: Where's the evidence?
Review in BMC public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Effectiveness of Partnerships With Commercial Actors to Improve Food Environments: A Systematic Review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025Pooled it
- Commercial determinants of health-a scoping review of research 'made in Germany'.European journal of public health · 2026Article
- Facilitators and barriers of public-private partnerships for universal health coverage in sub-Saharan Africa: a scoping review.Health policy and planning · 2026Article
- "Who the hell is upstream pushing them all in?" Reclaiming public health's defining metaphor to counter the commercial determinants of health.PLOS global public health · 2026Article
- Preliminary cost analysis of prosthodontic rehabilitation in partial and complete edentulism: evidence from a private clinical setting in Greece.Frontiers in public health · 2026Article
- Constructing and contesting industry's role in multistakeholder governance: a qualitative analysis of responses to WHO consultations.Globalization and health · 2025Article
- The Role of Physical Activity Opportunities and Local Authority Engagement in Promoting Healthy Living and Increasing Life Expectancy.Healthcare (Basel, Switzerland) · 2025Article
- Why addressing conflicts of interest is essential to progress in reducing commercially driven health harms: Lessons from tobacco.Future healthcare journal · 2025Article
- Article
- Integrating HIV prevention with family planning services for adolescent girls and young women in Uganda: perspectives of adolescent girls and young women, health care providers, and policymakers.Frontiers in reproductive health · 2025Article
- National Health Policy and factors predicting its implementation at the local level in Nepal: an exploratory cross-sectional study.Frontiers in public health · 2025Article
- Industry influence on public health policy formulation in the UK: a complex systems approach.Health promotion international · 2024Article
- Enhancing public health through multi-stakeholder collaboration in Africa.Annals of medicine and surgery (2012) · 2024Article
- Building a Systems Map: Applying Systems Thinking to Unhealthy Commodity Industry Influence on Public Health Policy.International journal of health policy and management · 2024Article
- The Role of Social Movements in Reducing Harmful Corporate Practices Comment on "National Public Health Surveillance of Corporations in Key Unhealthy Commodity Industries - A Scoping Review and Framework Synthesis".International journal of health policy and management · 2024Article
- High street retail environment interventions and their theorised impacts on health and wellbeing: A scoping review.PloS one · 2024Article
- Promoting health and productivity management in small companies through outreach-based public-private partnership: the Yokohama Linkworker Project.Frontiers in public health · 2024Article
- Nutrition policy reforms to address the double burden of malnutrition in Zambia: a prospective policy analysis.Health policy and planning · 2023Article
- Interventions to address global inequity in diabetes: international progress.Lancet (London, England) · 2023Article
- The ultra-processed food industry in Africa.Nature food · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough public-private partnerships have become common in the health sector, the evidence supporting their effectiveness is limited, and when the products or services provided by the private partner are harmful to health inherent conflicts of interest may be difficult to overcome. The objective of this study is to appraise the evidence describing process or effectiveness of public-private partnerships (PPPs) that aim to promote population health, and analyse how characteristics such as independence or competing interests influence the results of their evaluation.
methodsWe carried out a systematic search of Medline and Web of Science to identify scientific reports evaluating the process or effectiveness of PPPs that aim to promote population health. Two reviewers applied inclusion criteria, extracted and evaluated study quality. We classified PPPs according to the health problem tackled, the independence of the evaluation, and the potential for competition between business interests of the private partner and health promotion activity undertaken. We classified the conclusions of the evaluation as positive (supportive/tentatively supportive) or negative (semi-critical/critical).
resultsWe identified 36 studies evaluating 25 PPPs. Evaluations that were favourable to the use of PPPs in health promotion were more frequently classed as "not independent" and of poor quality. On the other hand, negative evaluations were more common when the PPP involved a private partner with a high potential for competition between the health promotion activity undertaken and their financial interests. PPPs that sought to prevent non-communicable diseases were more frequently negatively evaluated compared to PPPs tackling infectious disease or other types of health problem. Almost all of the evaluations evaluated process, with only 2 papers reporting quantitative health related outcomes.
conclusionsThere is still a lack of sound evidence supporting the effectiveness of public-private partnerships in health promotion, and the evidence base is skewed by non-independent evaluations. Public health actors should abstain from engaging in agreements with industries whose business interests have a high potential for competition with the health promotion activity undertaken.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.